NEW YORK (GenomeWeb News) – Oxford Nanopore Technologies today said that it has raised £40 million ($63.7 million) through a private placement of ordinary shares.

Participants in the round include new and existing investors from the US, UK, and mainland Europe, the company said. New investors included Odey Asset Management.

The funds will go toward development of Oxford Nanopore's commercial and manufacturing infrastructure, continued R&D work directed at nanopore sensing, and other corporate purposes.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Helix customers can purchase apps that interpret different aspects of their genome, Technology Review reports.

The New York Times reports that a number of companies and research institutes are pursuing gene therapies.

Salmon with shorter telomeres survive to make the trip back to their river homes, New Scientist reports.

In PLOS this week: vaginal microbiome composition, population patterns of Chagas-carrying Rhodnius ecuadoriensis, and more.